Skip to main content
LYEL logo

LYEL · Lyell Immunopharma, Inc. · Debt

Track LYEL — free
$11.96 -0.24 (-1.97%)
Market Cap
$298.96M
Shares
24.51M

Debt Profile

Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.

Debt data is being processed. Please check back later.
Key facts CIK 1806952 CUSIP 55083R203 13F (30d) 66 filings 65 filers Visit website Investor relations